X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Cancer Cachexia Companies

This report lists the top Cancer Cachexia companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cancer Cachexia industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Cancer Cachexia Top Companies

  1. Merck

  2. Aphios

  3. Helsinn Group

  4. Bristol-Myers Squibb

  5. Pfizer

*Disclaimer: Top companies sorted in no particular order

Cancer Cachexia Market Major Players

Cancer Cachexia Market Concentration

Cancer Cachexia  Market Concentration

Cancer Cachexia Company List

                            • Aeterna Zentaris

                            • Aphios Corporation

                            • Bristol-Myers Squibb Company

                            • Pfizer Inc.

                            • Helsinn Group

                            • Merck KGaA

                            • Artelo Biosciences Inc.

                            • NGM Biopharmaceuticals

                            • Aveo Oncology

                            • Aavogen Inc.

                            • Green Cross Wellbeing Corporation

                            • Cannabics Pharmaceuticals Inc.

                            • TCI Peptide Therapeutics

                            • Fresenius Kabi

                            • Tetra Bio-Pharma

                            • Actimed Therapeutics


                        Specific to Cancer Cachexia Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Cancer Cachexia Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)